1. Home
  2. GRDN vs STGW Comparison

GRDN vs STGW Comparison

Compare GRDN & STGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRDN
  • STGW
  • Stock Information
  • Founded
  • GRDN 2004
  • STGW 1980
  • Country
  • GRDN United States
  • STGW United States
  • Employees
  • GRDN N/A
  • STGW N/A
  • Industry
  • GRDN Retail-Drug Stores and Proprietary Stores
  • STGW
  • Sector
  • GRDN Consumer Staples
  • STGW
  • Exchange
  • GRDN Nasdaq
  • STGW Nasdaq
  • Market Cap
  • GRDN 1.8B
  • STGW 1.4B
  • IPO Year
  • GRDN 2024
  • STGW N/A
  • Fundamental
  • Price
  • GRDN $30.29
  • STGW $5.57
  • Analyst Decision
  • GRDN Strong Buy
  • STGW Buy
  • Analyst Count
  • GRDN 2
  • STGW 5
  • Target Price
  • GRDN $24.50
  • STGW $8.17
  • AVG Volume (30 Days)
  • GRDN 313.2K
  • STGW 884.5K
  • Earning Date
  • GRDN 11-11-2025
  • STGW 11-06-2025
  • Dividend Yield
  • GRDN N/A
  • STGW N/A
  • EPS Growth
  • GRDN N/A
  • STGW N/A
  • EPS
  • GRDN N/A
  • STGW N/A
  • Revenue
  • GRDN $1,326,604,000.00
  • STGW $2,858,547,000.00
  • Revenue This Year
  • GRDN $16.17
  • STGW $4.81
  • Revenue Next Year
  • GRDN $2.31
  • STGW $8.73
  • P/E Ratio
  • GRDN N/A
  • STGW N/A
  • Revenue Growth
  • GRDN 18.53
  • STGW 9.37
  • 52 Week Low
  • GRDN $14.16
  • STGW $4.03
  • 52 Week High
  • GRDN $30.27
  • STGW $8.18
  • Technical
  • Relative Strength Index (RSI)
  • GRDN 82.92
  • STGW 52.82
  • Support Level
  • GRDN $27.35
  • STGW $5.33
  • Resistance Level
  • GRDN $28.98
  • STGW $5.74
  • Average True Range (ATR)
  • GRDN 1.00
  • STGW 0.18
  • MACD
  • GRDN 0.21
  • STGW -0.04
  • Stochastic Oscillator
  • GRDN 99.81
  • STGW 52.17

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

About STGW Stagwell Inc.

Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: